Black Swift Group LLC Invests $3.24 Million in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Black Swift Group LLC purchased a new position in Intuitive Surgical, Inc. (NASDAQ:ISRG) in the 3rd quarter, HoldingsChannel reports. The fund purchased 6,600 shares of the medical equipment provider’s stock, valued at approximately $3,242,000. Intuitive Surgical accounts for about 0.7% of Black Swift Group LLC’s holdings, making the stock its 28th biggest position.

Other hedge funds also recently bought and sold shares of the company. International Assets Investment Management LLC boosted its position in shares of Intuitive Surgical by 49,383.6% during the third quarter. International Assets Investment Management LLC now owns 1,090,619 shares of the medical equipment provider’s stock valued at $535,788,000 after buying an additional 1,088,415 shares during the last quarter. Capital Research Global Investors bought a new stake in shares of Intuitive Surgical in the first quarter worth approximately $374,390,000. Vanguard Group Inc. raised its holdings in shares of Intuitive Surgical by 1.6% during the first quarter. Vanguard Group Inc. now owns 30,868,620 shares of the medical equipment provider’s stock valued at $12,319,358,000 after purchasing an additional 493,126 shares during the last quarter. Strategic Financial Concepts LLC lifted its position in Intuitive Surgical by 40,221.4% during the second quarter. Strategic Financial Concepts LLC now owns 266,121 shares of the medical equipment provider’s stock valued at $1,184,000 after purchasing an additional 265,461 shares during the period. Finally, GQG Partners LLC purchased a new stake in Intuitive Surgical in the first quarter worth approximately $99,523,000. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Up 0.2 %

Shares of ISRG stock opened at $537.50 on Thursday. The company’s fifty day simple moving average is $496.95 and its two-hundred day simple moving average is $455.65. Intuitive Surgical, Inc. has a 52 week low of $291.39 and a 52 week high of $542.59. The stock has a market cap of $191.45 billion, a P/E ratio of 86.28, a PEG ratio of 5.28 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, topping analysts’ consensus estimates of $1.24 by $0.32. The company had revenue of $2.04 billion for the quarter, compared to the consensus estimate of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. On average, analysts anticipate that Intuitive Surgical, Inc. will post 5.45 EPS for the current fiscal year.

Insider Buying and Selling

In related news, Director Amy L. Ladd sold 450 shares of the stock in a transaction dated Friday, September 13th. The shares were sold at an average price of $490.28, for a total value of $220,626.00. Following the completion of the transaction, the director now owns 821 shares of the company’s stock, valued at approximately $402,519.88. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In related news, Director Amy L. Ladd sold 450 shares of the stock in a transaction on Friday, September 13th. The stock was sold at an average price of $490.28, for a total transaction of $220,626.00. Following the sale, the director now owns 821 shares in the company, valued at approximately $402,519.88. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CEO Gary S. Guthart sold 18,151 shares of Intuitive Surgical stock in a transaction on Wednesday, October 30th. The stock was sold at an average price of $511.63, for a total transaction of $9,286,596.13. Following the transaction, the chief executive officer now directly owns 24,219 shares of the company’s stock, valued at $12,391,166.97. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 91,178 shares of company stock worth $45,897,071. Insiders own 0.90% of the company’s stock.

Analyst Ratings Changes

Several research firms have recently weighed in on ISRG. Oppenheimer reissued a “market perform” rating on shares of Intuitive Surgical in a report on Friday, October 18th. Evercore ISI reissued a “cautious” rating on shares of Intuitive Surgical in a report on Friday, October 18th. Redburn Atlantic upgraded Intuitive Surgical from a “neutral” rating to a “buy” rating and boosted their price target for the company from $380.00 to $510.00 in a research note on Friday, August 2nd. Leerink Partners increased their price objective on shares of Intuitive Surgical from $489.00 to $502.00 in a research note on Thursday, October 17th. Finally, Truist Financial boosted their target price on shares of Intuitive Surgical from $520.00 to $570.00 and gave the company a “buy” rating in a research report on Monday, October 14th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and fourteen have given a buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $513.74.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.